SBWire

Comprising of textual analysis and data tables, this in-depth and exclusive country report from Canadean provides a comprehensive view of the cider industry structure including analysis and profiles on trade mark owners and local operators. Brand volumes and market share are given by price segment, alcoholic strength and type (e.g. apple, pear, flavored). Consumption volumes are provided by pack mix (type, material, refill ability, pack size) and distribution channel (on- and off-premise). Other information includes market valuation/pricing data and new products are identified. All supported by market commentary.

GBI Research's new report, "Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes" provides information and analysis on the major trends and issues affecting biomarkers in the drug discovery process. The report describes the history of biomarkers and their role in fulfilling the unmet needs of the conventional drug discovery process. The drivers and barriers for the biomarkers market, along with the key issues faced in the application of biomarkers in the drug discovery process, are highlighted. The report discusses some important technologies being used in the discovery and validation of biomarkers. The integration of different types of biomarkers in each phase of the drug discovery and development process is also studied. Additionally, the report talks about the strategic consolidations that have taken place within the global biomarkers market. These include mergers, acquisitions, and strategic partnerships among companies involved in the manufacturing of biomarkers for drug discovery and research. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

GBI Research, the leading business intelligence provider, has released its latest research "Hepatitis C Therapeutics Market to 2018 - Expected Launch of GS-7977 in 2015 will Pave the Way for an Oral Interferon-free Combination Therapy", which provides insights into the global hepatitis C therapeutics market up to 2018. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts. The report examines the global hepatitis C treatment usage patterns, and the geographical distribution of hepatitis C therapeutics and markets across the US, the top five countries of Europe and Japan. The report also includes insights into the hepatitis C therapeutics R&D product pipeline and explores the competitive landscape, including major players in the hepatitis C therapeutics market. Finally, the report also includes analysis of the Mergers and Acquisitions (M&As) and licensing agreements that took place in the hepatitis C therapeutics market from 2010 to 2012.

GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia". An essential source of information and analysis on the Saudi Arabian healthcare, regulatory, and reimbursement landscape, this report identifies the key trends in the healthcare market, and provides insights on the demographic, regulatory, and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts. In 2011, the population of Saudi Arabia was approximately 28.17 million, growing at an annual rate of 3.8%. The mortality rate was almost steady at approximately four deaths per 1,000 population due to advances in the healthcare infrastructure and medical and diagnostic services. The value of the pharmaceutical market was estimated at $3.5 billion in 2011, and is expected to reach $5.6 billion by 2020, increasing at a projected Compound Annual Growth Rate (CAGR) of 5.4%. The medical device market was worth approximately $1.5 billion in 2011, and is expected to reach $2.3 billion by 2020, increasing at a projected CAGR of 4.5%.

Global Market Direct's pharmaceuticals report, "D-Pharm Ltd. - Product Pipeline Review - 2012" provides data on the D-Pharm Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Bacteremia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bacteremia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bacteremia. Bacteremia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Market Direct's pharmaceuticals report, "Medesis Pharma S.A. - Product Pipeline Review - 2012" provides data on the Medesis Pharma S.A.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Shenzhen Beike Biotechnology Co., Ltd. - Product Pipeline Review - 2012" provides data on the Shenzhen Beike Biotechnology Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Secondary Hyperparathyroidism - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Secondary Hyperparathyroidism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Secondary Hyperparathyroidism. Secondary Hyperparathyroidism - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Seo4anyone provides result-oriented SEO services for both large and small local businesses. Their services include search engine optimization (SEO), pay per click management (PPC), social media marketing (Facebook Twitter, Youtube, LinkedIn), viral marketing strategies, landing page conversion testing (A/B Testing), website optimization testing, email marketing and website design.

Neron Solutions is best professional Web Design & SEO Company in UK having expert web designers & developers offers services like Web Designing, Website Development, SEO Services, Applications development

Rolex watch retailing website, Melrose.com's founder and President, Krishan Agarwal shared a great news with the media on last Thursday. The 34 year old President of Melrose.com made a huge announcement of the season with which the enormous news got publicized to the globally spread watch enthusiasts that from the end of November, there are complete chances that the prices of luxurious watches offered by Melrose.com would drop significantly.

Rolex vendor, Melrose.com is yet again ready to offer its valued customers with special free gifts with every purchase over $4000. In the recent public announcement of Melrose.com, now they will be giving a complementary gift in the form an exquisite quality watch winder with every luxurious time line which prices over $4000.

Answeringcare.com offers medical answering services for only $99/month, functionality of medical answering services and why choose AnsweringCare.com

Liver Cancer - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Liver Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Liver Cancer.

Lifetime Bath is offering their customers a great holiday gift- chance to save up to 75% on bathroom steam showers. With the additional benefit of fast and free delivery and no hidden costs, customers are sure to enjoy their holiday shopping at LifetimeBath.com.

For years attorneys and law firms have relied on referrals and traditional media to increase their revenue. Now that Local Marketing 2.0’s Local Legal Division has expanded to the Sacramento and Napa areas, all of that is about to change.

Global Market Direct's pharmaceuticals report, "NeuroNascent, Inc. - Product Pipeline Review - 2012" provides data on the NeuroNascent, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Urethral Cancer - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Urethral Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Urethral Cancer. Urethral Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Cerebrovascular Disease - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Cerebrovascular Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cerebrovascular Disease. Cerebrovascular Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

BMI View: Per-capita spending on pharmaceuticals in Bahrain is expected to almost double in the 10 years to 2021, from some US$182 calculated for 2011, but will still remain a fraction of that in developed-country terms. Many multinational drug firms and other investors may continue to avoid Bahrain as the small size of the market will limit the potential return on their investment, especially given the unresolved political situation and the emergence of local manufacturing. Still, spending will generally remain driven by the expanding population, increasing consumption of medicines, government programmes targeting non-communicable diseases, significant expansion of healthcare facilities and the growing cost of medical imports.

Today's consumers are value-conscious, interactive, multicultural, health-driven, socially responsible and always connected. In developed markets, conspicuous consumption is out, with personal appearance and wellbeing taking priority over the accumulation of material possessions. Following on from "10 Global Macro Trends for the Next Five Years", this new global report discusses how the latest consumer trends will shape demand and impact marketing strategies going forward.

In 2011, the Belgian cigarette category was affected by a hike in tobacco prices, resulting in a significant decline in volume sales but positive growth for value sales. The decline in volume sales of cigarettes was due to cigarette smokers shifting to smoking tobacco but also the fact that the overall number of smokers is falling in Belgium. Over the review period Belgium witnessed a drop in both the number of smokers and smoking prevalence. That said, many cigarette smokers continued to opt...

Beauty and personal care recorded an improved performance in 2011, compared to the review period as a whole, owing to the rising rate of urbanisation in the country. Urbanisation, and attendant lifestyles, has helped to increase the demand for beauty and personal care products, as consumers strive to acclimatise to urban environments. Positive economic growth has boosted consumer disposable income and confidence, leading to higher spend on beauty and personal care. Marketing activities also...

The UK construction market valued GBP122.3 billion (US$196.1 billion) in 2011, and recorded a CAGR of -0.96% during the review period. The market is expected to grow at a CAGR of 0.05% over the forecast period. Residential construction was the largest market with 36.5% of the overall industry value, and recorded a CAGR of 0.12% during the review period. The residential construction market valued GBP44.6 billion (US$71.6 billion) in 2011. The UK currently faces a housing shortage, however, prospective buyers, particularly first-time buyers, are experiencing difficulty in obtaining mortgages due to high deposit requirements. Developers are also concerned about selling properties in the unstable economic conditions.